These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12958012)

  • 1. Hyperkalaemic paralysis.
    Jolobe OM
    Age Ageing; 2003 Sep; 32(5):556-7. PubMed ID: 12958012
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperkalaemic paralysis--a bizarre presentation of renal failure.
    Cumberbatch GL; Hampton TJ
    J Accid Emerg Med; 1999 May; 16(3):230-2. PubMed ID: 10353058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebral infarction as first manifestation of thrombocytopenia caused by pentosan polysulfate].
    Gironell A; Arboix A; Altés A; Martí-Vilalta JL
    Med Clin (Barc); 1997 Apr; 108(16):636. PubMed ID: 9303962
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidural hematoma after epidural steroid injection: a possible association with use of pentosan polysulfate sodium.
    Siddiqui MN; Ranasinghe JS; Siddiqui S
    Anesthesiology; 2001 Nov; 95(5):1307. PubMed ID: 11685018
    [No Abstract]   [Full Text] [Related]  

  • 5. Large Subfoveal Vitelliform Lesions in a Case of Pentosan Polysulfate Maculopathy.
    Wannamaker KW; Sisk RA
    Ophthalmology; 2020 Dec; 127(12):1641. PubMed ID: 33222775
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium.
    Huckfeldt RM; Vavvas DG
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):656-659. PubMed ID: 31671200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misleading report of massive bleeding in a patient taking pentosan polysulfate.
    Parsons CL
    Arch Intern Med; 2003 Jan; 163(1):119; authors reply 119-20. PubMed ID: 12523927
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute paralysis in a uremic patient.
    Wang CC; Wu CC; Shiang JC; Tsai MK; Chen IH
    Am J Med; 2010 Jun; 123(6):e7-8. PubMed ID: 20569745
    [No Abstract]   [Full Text] [Related]  

  • 9. Spinal anesthesia in a patient receiving pentosan polysulfate sodium.
    Cambic CR; Higgins N
    Int J Obstet Anesth; 2009 Oct; 18(4):425-6. PubMed ID: 19733051
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary hyperkalaemic paralysis.
    Evers S; Engelien A; Karsch V; Hund M
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):249-52. PubMed ID: 9489541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalaemic muscle paresis--side-effect of prostaglandin inhibition in a haemodialysis patient.
    Nielsen EH
    Nephrol Dial Transplant; 1999 Feb; 14(2):480-2. PubMed ID: 10069220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Periodic paralysis].
    Gamstorp I
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):798-800. PubMed ID: 5089802
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I trial of pentosan polysulfate.
    Swain SM; Parker B; Wellstein A; Lippman ME; Steakley C; DeLap R
    Invest New Drugs; 1995; 13(1):55-62. PubMed ID: 7499109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization.
    Sacher C; Hunzelmann N
    Allergy; 2003 Dec; 58(12):1318-9. PubMed ID: 14616114
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative Management of Patients Receiving Pentosan Polysulfate Sodium (Elmiron).
    Narouze S; Provenzano D; Rech GR
    Reg Anesth Pain Med; 2016; 41(5):658. PubMed ID: 27547908
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperkalaemic ascending paralysis.
    Walter E; Gibbins N; Vandersteen A; Kinton L; Wark P; Jonas M
    J R Soc Med; 2004 Jul; 97(7):330-1. PubMed ID: 15229259
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperkalaemic paralysis resembling Guillain-Barré syndrome.
    Livingstone IR; Cumming WJ
    Lancet; 1979 Nov; 2(8149):963-4. PubMed ID: 91060
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct transition from hypo- to hyperkalaemic paralysis during potassium treatment of familial periodic paralysis. A case.
    Sestoft L
    Dan Med Bull; 1967 Jun; 14(7):157-60. PubMed ID: 6047305
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary hyperkalaemic paralysis.
    Gledhill RF
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):614. PubMed ID: 9771811
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of corticotropin-induced potassium changes in the diagnosis of both hypo- and hyperkalemic periodic paralysis.
    Streeten DH; Speller PJ; Fellerman H
    Eur Neurol; 1993; 33(2):103-8. PubMed ID: 8385612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.